Literature DB >> 36016701

Formation of bilateral arteriovenous malformations.

Makoto Shiraishi1,2, Masakazu Kurita1, Mitsunaga Narushima2, Chihena Hansini Banda1, Mutsumi Okazaki1.   

Abstract

Entities:  

Year:  2022        PMID: 36016701      PMCID: PMC9395753          DOI: 10.1016/j.jvscit.2022.05.009

Source DB:  PubMed          Journal:  J Vasc Surg Cases Innov Tech        ISSN: 2468-4287


× No keyword cloud information.
A 58-year-old Japanese man, with no family history of vascular anomalies, had presented with swelling of the right lower extremity (A). He did not have a thrill, edema, or any symptoms specific to well-described syndromes. Computed tomography angiography revealed an arteriovenous (AV) shunt and a mosaic pattern of various signal intensities, indicating a chronic expanding hematoma in the right lower extremity (A [arrowhead]; and B/Cover). It also described an AV shunt in the left lower extremity (A [arrow] and B/Cover). These findings suggested the presence of bilateral AV malformations (AVMs). He underwent partial resection of the AVM lesion on the right side because of continuous bleeding (S1 [arrow]; and S2-S4). He had had anemia before surgery; however, he had recovered. No other abnormal changes were observed in the laboratory tests. Genetic examinations were not performed because they are not routine for the diagnosis of AVMs. The lesions were well-controlled even 1 year after the surgery (S5). The patient provided written informed consent for the report of his case details and relevant imaging studies.

Discussion

An extracranial AVM is a type of vascular anomaly characterized by AV shunts. Similar to venous malformations, sporadic AVMs are thought to arise from somatic mosaicism caused by somatic mutations at embryologic stages., Because the number of reported bilateral extracranial AVMs has been far less than that of unilateral AVMs, one working hypothesis is that a unilateral AVM can arise from mutations that have occurred in the leg after lateralization (C, unilateral model). For bilateral sporadic lesions, another working hypothesis is that the first hit mutations occur early in embryogenesis before lateralization. In the present case, we believe that site-specific factors might have played a significant role in the manifestation of the lesions because of the high similarity in the location of the bilateral lesions (C; bilateral model). Because an asymptomatic AVM was coincidentally found at an identical location on the contralateral side of the symptomatic AVM lesion, it is possible that the number of multiple or bilateral AVM cases could be greater than previously reported. We believe the details of the present patient will help in understanding the etiology and pathogenesis of “sporadic” AVMs in the future.
  5 in total

1.  Extracranial arteriovenous malformations: natural progression and recurrence after treatment.

Authors:  Allen S Liu; John B Mulliken; David Zurakowski; Steven J Fishman; Arin K Greene
Journal:  Plast Reconstr Surg       Date:  2010-04       Impact factor: 4.730

Review 2.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

3.  Bilateral arteriovenous malformation of the mandible.

Authors:  R A Sofferman; G W Summers
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-09       Impact factor: 1.547

4.  Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy.

Authors:  Lara Al-Olabi; Satyamaanasa Polubothu; Katherine Dowsett; Katrina A Andrews; Paulina Stadnik; Agnel P Joseph; Rachel Knox; Alan Pittman; Graeme Clark; William Baird; Neil Bulstrode; Mary Glover; Kristiana Gordon; Darren Hargrave; Susan M Huson; Thomas S Jacques; Gregory James; Hannah Kondolf; Loshan Kangesu; Kim M Keppler-Noreuil; Amjad Khan; Marjorie J Lindhurst; Mark Lipson; Sahar Mansour; Justine O'Hara; Caroline Mahon; Anda Mosica; Celia Moss; Aditi Murthy; Juling Ong; Victoria E Parker; Jean-Baptiste Rivière; Julie C Sapp; Neil J Sebire; Rahul Shah; Branavan Sivakumar; Anna Thomas; Alex Virasami; Regula Waelchli; Zhiqiang Zeng; Leslie G Biesecker; Alex Barnacle; Maya Topf; Robert K Semple; E Elizabeth Patton; Veronica A Kinsler
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.